| __timestamp | ACADIA Pharmaceuticals Inc. | Catalyst Pharmaceuticals, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 32748000 | 4473654 |
| Thursday, January 1, 2015 | 90804000 | 8597010 |
| Friday, January 1, 2016 | 186456000 | 7910260 |
| Sunday, January 1, 2017 | 255062000 | 7304399 |
| Monday, January 1, 2018 | 265758000 | 15875961 |
| Tuesday, January 1, 2019 | 325638000 | 36881187 |
| Wednesday, January 1, 2020 | 388661000 | 44233754 |
| Friday, January 1, 2021 | 396028000 | 49628000 |
| Saturday, January 1, 2022 | 369090000 | 58183000 |
| Sunday, January 1, 2023 | 402466000 | 133710000 |
Unlocking the unknown
In the competitive landscape of pharmaceuticals, understanding financial trends is crucial. Over the past decade, ACADIA Pharmaceuticals Inc. and Catalyst Pharmaceuticals, Inc. have shown distinct trajectories in their Selling, General, and Administrative (SG&A) expenses. From 2014 to 2023, ACADIA's SG&A expenses surged by over 1,100%, peaking in 2023. This reflects their aggressive expansion and investment in operational capabilities. In contrast, Catalyst Pharmaceuticals, Inc. exhibited a more conservative growth, with SG&A expenses increasing by approximately 2,900% over the same period, indicating a strategic scaling of operations. Notably, 2023 marked a significant leap for Catalyst, with expenses nearly tripling from the previous year, suggesting a pivotal shift in their business strategy. These trends highlight the dynamic nature of the pharmaceutical industry, where strategic financial management can significantly impact a company's market position.
Who Optimizes SG&A Costs Better? Merck & Co., Inc. or ACADIA Pharmaceuticals Inc.
Selling, General, and Administrative Costs: Insmed Incorporated vs ACADIA Pharmaceuticals Inc.
Sarepta Therapeutics, Inc. vs Catalyst Pharmaceuticals, Inc.: SG&A Expense Trends
Ionis Pharmaceuticals, Inc. or Catalyst Pharmaceuticals, Inc.: Who Manages SG&A Costs Better?
Cost Management Insights: SG&A Expenses for Alpine Immune Sciences, Inc. and ACADIA Pharmaceuticals Inc.
Breaking Down SG&A Expenses: Ultragenyx Pharmaceutical Inc. vs ACADIA Pharmaceuticals Inc.
CymaBay Therapeutics, Inc. vs ACADIA Pharmaceuticals Inc.: SG&A Expense Trends
SG&A Efficiency Analysis: Comparing Veracyte, Inc. and ACADIA Pharmaceuticals Inc.
Comparing SG&A Expenses: ACADIA Pharmaceuticals Inc. vs Soleno Therapeutics, Inc. Trends and Insights
Comparing SG&A Expenses: ACADIA Pharmaceuticals Inc. vs Amphastar Pharmaceuticals, Inc. Trends and Insights
Comparing SG&A Expenses: Catalyst Pharmaceuticals, Inc. vs Galapagos NV Trends and Insights
Comparing SG&A Expenses: Catalyst Pharmaceuticals, Inc. vs Xencor, Inc. Trends and Insights